Thesis Abstract

Abstract
This thesis investigates the impact of probiotics supplementation on gut health in individuals with Type 2 Diabetes Mellitus (T2DM) through a randomized controlled trial. The study aims to evaluate the potential benefits of probiotics in managing T2DM by focusing on their effects on gut health parameters. The research design involves a randomized controlled trial with participants diagnosed with T2DM who will be randomly assigned to either a probiotics supplementation group or a control group. Various gut health indicators, such as gut microbiota composition, inflammation markers, and metabolic parameters, will be assessed before and after the intervention period. The study will also explore the potential mechanisms through which probiotics may exert their beneficial effects on gut health and glycemic control in individuals with T2DM. The introduction provides an overview of the increasing prevalence of T2DM globally and the challenges associated with its management. The background of the study highlights the role of gut health in T2DM and the emerging evidence supporting the use of probiotics as a potential adjunct therapy. The problem statement emphasizes the gaps in current knowledge regarding the specific effects of probiotics on gut health in individuals with T2DM. The objectives of the study include evaluating the impact of probiotics supplementation on gut health parameters, elucidating the mechanisms underlying any observed effects, and assessing the implications for T2DM management. The literature review delves into existing research on the relationship between gut health, probiotics, and T2DM. It covers topics such as the gut microbiota-host interaction, the role of inflammation in T2DM pathogenesis, and the potential of probiotics to modulate gut health and metabolic outcomes. The review synthesizes evidence from both animal and human studies to provide a comprehensive understanding of the current state of knowledge in this field. The research methodology outlines the study design, participant selection criteria, intervention protocol, outcome measures, and statistical analysis plan. It describes the randomized controlled trial format, including the randomization process, blinding procedures, and data collection methods. The methodology also details the assessments of gut health parameters, metabolic markers, and inflammatory indicators to be conducted at baseline and post-intervention. The results and discussion chapters present the findings of the study, including changes in gut health parameters, metabolic outcomes, and inflammatory markers following probiotics supplementation. The discussion interprets the results in the context of existing literature, explores the potential mechanisms driving the observed effects, and discusses the implications for T2DM management. Possible limitations of the study, such as sample size constraints and methodological considerations, are also addressed. In conclusion, the study contributes to the growing body of evidence supporting the potential benefits of probiotics supplementation for improving gut health and metabolic outcomes in individuals with T2DM. The findings have implications for the development of targeted interventions to optimize gut health and glycemic control in this population. Future research directions may focus on exploring specific probiotic strains, dosages, and treatment durations to further enhance the efficacy of probiotics-based therapies for T2DM management.

Thesis Overview

The project titled "The Impact of Probiotics Supplementation on Gut Health in Individuals with Type 2 Diabetes Mellitus: A Randomized Controlled Trial" aims to investigate the potential benefits of probiotics supplementation in improving gut health among individuals diagnosed with Type 2 Diabetes Mellitus (T2DM). Type 2 Diabetes Mellitus is a chronic metabolic disorder characterized by insulin resistance, hyperglycemia, and inflammation, which can lead to various complications, including gastrointestinal issues related to gut dysbiosis. The study will focus on the impact of probiotics, which are live microorganisms known to confer health benefits when consumed in adequate amounts, on the gut microbiota composition and function in individuals with T2DM. Probiotics have been shown to modulate the gut microbiota, improve gut barrier function, reduce inflammation, and enhance metabolic health in various populations, but their specific effects on individuals with T2DM remain to be fully elucidated. The randomized controlled trial design will allow for a rigorous evaluation of the effects of probiotics supplementation on gut health parameters, such as gut microbiota composition, intestinal permeability, inflammation markers, and metabolic profiles, in individuals with T2DM. The study will involve a carefully selected sample of participants with T2DM who will be randomly assigned to either a probiotics supplementation group or a placebo group to assess the specific impact of probiotics on gut health outcomes. By investigating the relationship between probiotics supplementation and gut health in individuals with T2DM, this research aims to contribute valuable insights into the potential role of probiotics as a therapeutic intervention for improving gastrointestinal health and metabolic outcomes in this population. The findings from this study could have important implications for the development of targeted probiotic interventions to support the management of T2DM and associated gut-related complications.